BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8236145)

  • 1. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I.
    Arvieux J; Roussel B; Pouzol P; Colomb MG
    Thromb Haemost; 1993 Aug; 70(2):336-41. PubMed ID: 8236145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding.
    Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE
    Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fc gamma receptor-mediated interplatelet activation by a monoclonal antibody against beta 2 microglobulin.
    Rubinstein E; Boucheix C; Urso I; Carroll RC
    J Immunol; 1991 Nov; 147(9):3040-6. PubMed ID: 1833461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of platelet activation induced by HLA antibodies associated with alloimmune thrombocytopenia.
    Christie DJ; Leja DN; Carlson DL; Swinehart CD
    J Lab Clin Med; 1993 Mar; 121(3):437-43. PubMed ID: 7680369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fc gamma II receptor-mediated platelet activation induced by anti-CD9 monoclonal antibody opens Ca2+ channels which are distinct from those associated with Ca2+ store depletion.
    Kuroda K; Ozaki Y; Qi R; Asazuma N; Yatomi Y; Satoh K; Nomura S; Suzuki M; Kume S
    J Immunol; 1995 Nov; 155(9):4427-36. PubMed ID: 7594604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activation induces increased Fc gamma receptor expression.
    McCrae KR; Shattil SJ; Cines DB
    J Immunol; 1990 May; 144(10):3920-7. PubMed ID: 2139675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet pro-aggregatory effects of CD40L monoclonal antibody.
    Mirabet M; Barrabés JA; Quiroga A; Garcia-Dorado D
    Mol Immunol; 2008 Feb; 45(4):937-44. PubMed ID: 17959249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Off-target platelet activation in macaques unique to a therapeutic monoclonal antibody.
    Santostefano MJ; Kirchner J; Vissinga C; Fort M; Lear S; Pan WJ; Prince PJ; Hensley KM; Tran D; Rock D; Vargas HM; Narayanan P; Jawando R; Rees W; Reindel JF; Reynhardt K; Everds N
    Toxicol Pathol; 2012 Aug; 40(6):899-917. PubMed ID: 22552394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
    Shido K; Ahmad G; Hsu L; Kamiyama M
    J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa].
    Mazurov AV; Pevzner DV; Khaspekova SG; Dudnik OA; Byzova TV; Vlasik TN; Bakharev VN; Pistsov MIu; Staroverov II; Ruda MIa
    Ter Arkh; 2001; 73(9):66-73. PubMed ID: 11642086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa.
    Christopoulos C; Mackie I; Lahiri A; Machin S
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):729-37. PubMed ID: 8292722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of human platelet specific functional antibody and its fragments].
    Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil activation by anti-beta 2 glycoprotein I monoclonal antibodies via Fc gamma receptor II.
    Arvieux J; Jacob MC; Roussel B; Bensa JC; Colomb MG
    J Leukoc Biol; 1995 Mar; 57(3):387-94. PubMed ID: 7884309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of beta2-glycoprotein I and monoclonal anticardiolipin antibodies in platelet interaction with subendothelium under flow conditions.
    Font J; Espinosa G; Tàssies D; Pino M; Khamashta MA; Gallart T; Cervera R; Escolar G; Hughes GR; Ingelmo M; Ordinas A; Reverter JC
    Arthritis Rheum; 2002 Dec; 46(12):3283-9. PubMed ID: 12483733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine diphosphate-induced aggregation of human platelets in flow through tubes: III. Shear and extrinsic fibrinogen-dependent effects.
    Goldsmith HL; Frojmovic MM; Braovac S; McIntosh F; Wong T
    Thromb Haemost; 1994 Jan; 71(1):78-90. PubMed ID: 8165650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
    Lackner KJ; von Landenberg C; Barlage S; Schmitz G
    Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.